Sunday, 25 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Bayer HealthCare and JD Healthcare Partner on Women's Health Ecosystem
CompanyDeals

Bayer HealthCare and JD Healthcare Partner on Women’s Health Ecosystem

March 4, 2025
Huadong Medicine's HDM1005 Receives NMPA Approval for Clinical Trials
CompanyDrug

Huadong Medicine’s HDM1005 Receives NMPA Approval for Clinical Trials

March 4, 2025
Bio-heart's Iberis RDN System Completes First Commercial Surgery in Germany
CompanyMedical Device

Bio-heart’s Iberis RDN System Completes First Commercial Surgery in Germany

March 4, 2025
Geneseeq and MGI Tech Form Global Partnership for Oncology Solutions
CompanyDeals

Geneseeq and MGI Tech Form Global Partnership for Oncology Solutions

March 4, 2025
Tonghua Dongbao's Tongboli Under GMP Inspection in Egypt
CompanyDrug

Tonghua Dongbao’s Tongboli Under GMP Inspection in Egypt

March 4, 2025
United Laboratories' UBT251 Receives FDA Green Light for Phase II CKD Study
CompanyDrug

United Laboratories’ UBT251 Receives FDA Green Light for Phase II CKD Study

March 4, 2025
CStone Pharmaceuticals Doses First Patient in CS2009 Phase I Study for Solid Tumors
CompanyDrug

CStone Pharmaceuticals Doses First Patient in CS2009 Phase I Study for Solid Tumors

March 4, 2025
AbbVie Enters Obesity Field with Gubra's GUB014295 Licensing Deal
CompanyDeals

AbbVie Enters Obesity Field with Gubra’s GUB014295 Licensing Deal

March 3, 2025
Zeiss Group's VISUMAX 800 with SMILE pro Software Approved by China's NMPA
CompanyMedical Device

Zeiss Group’s VISUMAX 800 with SMILE pro Software Approved by China’s NMPA

March 3, 2025
Laekna's LAE120 Receives FDA Approval for Solid Tumor Clinical Trials
CompanyDrug

Laekna’s LAE120 Receives FDA Approval for Solid Tumor Clinical Trials

March 3, 2025
SynerK's SNK-2726 Gets FDA Green Light for Phase I Hypertension Study
CompanyDrug

SynerK’s SNK-2726 Gets FDA Green Light for Phase I Hypertension Study

March 3, 2025
Omron Healthcare and China Jo-Jo Drugstores Launch Atrial Fibrillation Screening Zone
CompanyDeals

Omron Healthcare and China Jo-Jo Drugstores Launch Atrial Fibrillation Screening Zone

March 3, 2025
1 2 … 28 29 30 31 32
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up